EXPECTATIONS FOR FUTURE CONSUMPTION
Our estimates and analyses support financial prioritisation in the healthcare system.
Danish Regions use the estimates in their annual negotiations with the Government on regional finances, and the individual regions use them when planning their budgets.
The estimates cover both increased costs associated with new medicines and savings from lower-cost alternatives.
METHOD AND SOURCES
We work systematically to create an overview of upcoming medicines and use several different sources.
Among other things, we collect data from the European Medicines Agency (EMA) and supplement this with knowledge from commercial databases and international newsletters.
In addition, we regularly hold pipeline meetings with pharmaceutical companies. These provide insight into the products they expect to introduce to the Danish market in the coming years.
We also participate in national and international conferences and networks. This helps ensure that we stay up to date and remain at the forefront of developments in the field.
!
We are open to dialogue
Horizon Scanning is always open to dialogue with interested stakeholders in the healthcare sector. You are very welcome to contact one of our specialists – both regarding general questions or specific data.
Read more
Horizon Scanning
Horizon Scanning overviews
Horizon Scanning prepares lists of new medicines, extensions of indication and other extensions undergoing evaluation by the EMA.
READ MORE
Horizon Scanning
Latest news
If you would like to receive news from Amgros directly in your inbox, sign up for our newsletter. You can choose between general news or the latest news from Horizon Scanning.
SIGN UP
Horizon Scanning
Find your way through EMA
Horizon Scanning draws, among other sources, on information from the European Medicines Agency (EMA). We continuously register and monitor pharmaceutical companies’ applications to the EMA. We communicate the collected information through the briefings and overviews that we publish on our website.
READ MORE